Evidence map›Paper›PMID 27088111›Full record

ArticleReceptors & clinical investigation2016

Dectin-1 in the control of Th2-type T cell responses.

Katherine Upchurch, SangKon Oh, HyeMee Joo

Open access · diamondAbstract read
In one paragraph

Article in Receptors & clinical investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. A promisingClinical and experimental vaccine research · 2025
    Review
  2. Article
  3. Co-infection ofFrontiers in cellular and infection microbiology · 2020
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katherine UpchurchBaylor Institute for Immunology Research, Dallas, TX 75204, USA; Baylor University, Institute for Biomedical Studies, Waco, TX 76706, USA.
SangKon OhBaylor Institute for Immunology Research, Dallas, TX 75204, USA; Baylor University, Institute for Biomedical Studies, Waco, TX 76706, USA.
HyeMee JooBaylor Institute for Immunology Research, Dallas, TX 75204, USA; Baylor University, Institute for Biomedical Studies, Waco, TX 76706, USA.
Baylor University · US

Funding

Controlling Allergen-specific Th2-type Responses by Targeting DC Surface LectinsR21AI101810 · NIAID · BAYLOR RESEARCH INSTITUTE · PI OH, SANGKON · 2012 to 2013
$429k
NIAID NIH HHS R21 AI101810
6 · The paper itself

Abstract

Dendritic cells (DCs) are major antigen-presenting cells (APCs) that can induce and control host immune responses. DCs express pattern recognition receptors (PRRs), which can translate external and internal triggers into different types of T cell responses. The types of CD4

Identifiers

PMID27088111
PMCPMC4831730
OpenAlexW2229583070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.